Page 53 - 《中国药房》2024年17期

参考文献 ted improvement in mitochondrial dysfunction[J]. Food
[ 1 ] TINCOPA M A，LOOMBA R. Non-invasive diagnosis Funct，2023，14（12）：5562-5575.
and monitoring of non-alcoholic fatty liver disease and [11] SHEN Q，CHEN Y E，SHI J X，et al. Asperuloside allevia-
non-alcoholic steatohepatitis[J]. Lancet Gastroenterol tes lipid accumulation and inflammation in HFD-induced
Hepatol，2023，8（7）：660-670. NAFLD via AMPK signaling pathway and NLRP3 inflam‐
[ 2 ] HAN S K，BAIK S K，KIM M Y. Non-alcoholic fatty liver masome[J]. Eur J Pharmacol，2023，942：175504.
disease：definition and subtypes[J]. Clin Mol Hepatol， [12] 李芳，陈华伟，钟军华，等. 槲皮苷对非酒精性脂肪肝大
2023，29（Suppl.）：S5-S16. 鼠肝纤维化和炎症作用研究[J]. 中国临床药理学杂志，
2023，39（12）：1753-1757.
[ 3 ] RINELLA M E，NEUSCHWANDER-TETRI B A，
LI F，CHEN H W，ZHONG J H，et al. Effect of quercitrin
SIDDIQUI M S，et al. AASLD practice guidance on the
clinical assessment and management of nonalcoholic fatty on liver fibrosis and inflammation in non-alcoholic fatty
liver rats[J]. Chin J Clin Pharmacol，2023，39（12）：1753-
liver disease[J]. Hepatology，2023，77（5）：1797-1835.
1757.
[ 4 ] HAMMERICH L，TACKE F. Hepatic inflammatory re‐
[13] 丁静，张斌，魏冬梅，等. 盐酸小檗碱对非酒精性脂肪肝
sponses in liver fibrosis[J]. Nat Rev Gastroenterol Hepa‐
大鼠肝脏氧化应激水平及Nrf2表达的影响[J]. 免疫学杂
tol，2023，20（10）：633-646.
志，2020，36（3）：201-207.
[ 5 ] TAKESHITA Y，HONDA M，HARADA K，et al. Com‐
DING J，ZHANG B，WEI D M，et al. Effects of berberine
parison of tofogliflozin and glimepiride effects on nonal‐
hydrochloride on liver oxidative stress and nuclear Nrf2
coholic fatty liver disease in participants with type 2 diabe‐
expression in rats with nonalcoholic fatty liver disease[J].
tes：a randomized，48-week，open-label，active-controlled
Immunol J，2020，36（3）：201-207.
trial[J]. Diabetes Care，2022，45（9）：2064-2075.
[14] LEE K C，WU P S，LIN H C. Pathogenesis and treatment
[ 6 ] FENG F Z，GONG W Y，LI S Y，et al. Inhibitory effect of
of non-alcoholic steatohepatitis and its fibrosis[J]. Clin
resveratrol on LPS-induced glomerular mesangial cells
Mol Hepatol，2023，29（1）：77-98.
proliferation and TGF-β1 expression via sphingosine ki‐
[15] FAN X D，ZHOU C，HUANG C，et al. Asperuloside ame‐
nase 1 pathway[J]. Chin J Integr Med，2023，29（6）：
liorates lipopolysaccharide-induced primary human perio-
500-507.
dontal ligament cell injury by decreasing TLR4 expres‐
[ 7 ] ZHOU Z S，KONG C F，SUN J R，et al. Fisetin amelio‐
sion and NF-κB activation[J]. Arch Oral Biol，2021，129：
rates alcohol-induced liver injury through regulating
105199.
SIRT1 and SphK1 pathway[J]. 2022，50（8）：2171-2184.
[16] KONG Z Y，LIU C H，OLATUNJI O J. Asperuloside at‐
[ 8 ] ABDELRAHEEM K M，YOUNIS N N，SHAHEEN M A，
tenuates cadmium-induced toxicity by inhibiting oxidative
et al. Raspberry ketone improves non-alcoholic fatty liver
stress，inflammation，fibrosis and apoptosis in rats[J]. Sci
disease induced in rats by modulating sphingosine kinase/ Rep，2023，13（1）：5698.
sphingosine-1-phosphate and toll-like receptor 4 pathways
[17] JOZEFCZUK E，SZCZEPANIAK P，GUZIK T J，et al. Si‐
[J]. J Pharm Pharmacol，2023，75（7）：985-994.
lencing of Sphingosine kinase 1 affects maturation path‐
[ 9 ] UCZAY M，PFLÜGER P，PICADA J N，et al. Geniposide ways in mouse neonatal cardiomyocytes[J]. Int J Mol Sci，
and asperuloside alter the COX-2 and GluN2B receptor 2021，22（7）：3616.
expression after pilocarpine-induced seizures in mice[J]. [18] MONTEFUSCO D，JAMIL M，MACZIS M A，et al.
Naunyn Schmiedebergs Arch Pharmacol，2023，396（5）： Sphingosine kinase 1 mediates sexual dimorphism in fi‐
951-962. brosis in a mouse model of NASH[J]. Mol Metab，2022，
[10] CHEN Q，ZHANG Q J，AMROUCHE A T，et al. Asperu‐ 62：101523.
loside，the bioactive compound in the edible Eucommia ul‐ （收稿日期：2024-03-18 修回日期：2024-08-01）
moides male flower，delays muscle aging by daf-16 media- （编辑：唐晓莲）

中国药房 2024年第35卷第17期 China Pharmacy 2024 Vol. 35 No. 17 · 2107 ·